(Total Views: 27)
Posted On: 08/21/2025 12:05:52 PM
Post# of 12197

$ADTX Aditxt’s Subsidiary, Pearsanta, Inc. Engages Spartan Capital as Lead Underwriter for its Planned IPO Intending to Drive Clinical Validation and Commercial Rollout of Its Mitomic™ Platform Technology for Early Detection of Cancers and Other Diseases
https://businesswire.com/news/home/2025072947...r-Diseases
https://businesswire.com/news/home/2025072947...r-Diseases

